Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Nurse receiving the Pfizer-BioNTech vaccine in Santiago, Chile. Photo: David Lillo/Ministerio de Salud de Chile via Getty Images
Chile became the first country in South America to begin coronavirus vaccinations on Thursday after receiving its first 10,000 Pfizer-BioNTech doses, Reuters reports.
The big picture: The country bought 10 million doses from Pfizer-BioNTech and is expected to receive 240,000 doses in January, per Reuters.
- It has secured 36 million doses overall, Bloomberg writes.
Details: Medical workers were the first to be inoculated. Chilean President Sebastián Piñera said people with chronic illnesses and the elderly would be the next groups to receive the vaccine, per AP.
By the numbers: Chile has more than 596,000 confirmed COVID cases and over 16,000 deaths, according to data from Johns Hopkins University.